Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GlaxoSmithKline bails on Basilea's eczema drug, nixing a $72M payout
GlaxoSmithKline bails on Basilea's eczema drug, nixing a $72M payout
GlaxoSmithKline bails on Basilea's eczema drug, nixing a $72M payout
Submitted by
admin
on January 22, 2016 - 9:31pm
Source:
Fierce Biotech
News Tags:
GSK
Basilea
eczema
alitretinoin
Headline:
GlaxoSmithKline bails on Basilea's eczema drug, nixing a $72M payout
Do Not Allow Advertisers to Use My Personal information
